These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 34517210)

  • 1. TUBA1C expression promotes proliferation by regulating the cell cycle and indicates poor prognosis in glioma.
    Gui S; Chen P; Liu Y; Chen Q; Cheng T; Lv S; Zhou T; Song Z; Xiao J; He W; Yuan S; Cheng Z
    Biochem Biophys Res Commun; 2021 Nov; 577():130-138. PubMed ID: 34517210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The oncogenic role of tubulin alpha-1c chain in human tumours.
    Hu X; Zhu H; Chen B; He X; Shen Y; Zhang X; Xu Y; Xu X
    BMC Cancer; 2022 May; 22(1):498. PubMed ID: 35513790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of SOX9 indicates a better prognosis and inhibits the growth of glioma cells by inducing cell cycle arrest.
    Gao J; Zhang JY; Li YH; Ren F
    Int J Clin Exp Pathol; 2015; 8(9):10130-8. PubMed ID: 26617720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients.
    Li H; Yu L; Liu J; Bian X; Shi C; Sun C; Zhou X; Wen Y; Hua D; Zhao S; Ren L; An T; Luo W; Wang Q; Yu S
    Oncotarget; 2017 Mar; 8(12):19723-19737. PubMed ID: 28160566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CKAP2L Knockdown Exerts Antitumor Effects by Increasing miR-4496 in Glioblastoma Cell Lines.
    Li YF; Tsai WC; Chou CH; Huang LC; Huang SM; Hueng DY; Tsai CK
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TUBA1C: a new potential target of LncRNA EGFR-AS1 promotes gastric cancer progression.
    Wang H; Cui H; Yang X; Peng L
    BMC Cancer; 2023 Mar; 23(1):258. PubMed ID: 36941595
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Li J; Zhong J; Tang A; Yin J; Li S
    Biomark Med; 2024; 18(8):385-397. PubMed ID: 38913622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated bioinformatics analysis and experimental validation on malignant progression and immune cell infiltration of LTBP2 in gliomas.
    Gao L; Zhang R; Zhang W; Lan Y; Li X; Cai Q; Liu J
    BMC Cancer; 2024 Oct; 24(1):1252. PubMed ID: 39390437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
    Li Y; Ma X; Wang Y; Li G
    Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-338-5p plays a tumor suppressor role in glioma through inhibition of the MAPK-signaling pathway by binding to FOXD1.
    Ma XL; Shang F; Ni W; Zhu J; Luo B; Zhang YQ
    J Cancer Res Clin Oncol; 2018 Dec; 144(12):2351-2366. PubMed ID: 30225541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RBM17 controls apoptosis and proliferation to promote Glioma progression.
    Lu J; Li Q; Cai L; Zhu Z; Guan J; Wang C; Xia J; Xia L; Wen M; Zheng W; Su Z; Wang C
    Biochem Biophys Res Commun; 2018 Oct; 505(1):20-28. PubMed ID: 30227940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel chromatin architectural regulator SND1 promotes glioma proliferation and invasion and predicts the prognosis of patients.
    Yu L; Xu J; Liu J; Zhang H; Sun C; Wang Q; Shi C; Zhou X; Hua D; Luo W; Bian X; Yu S
    Neuro Oncol; 2019 Jun; 21(6):742-754. PubMed ID: 30753603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-146b-5p functions as a tumor suppressor by targeting TRAF6 and predicts the prognosis of human gliomas.
    Liu J; Xu J; Li H; Sun C; Yu L; Li Y; Shi C; Zhou X; Bian X; Ping Y; Wen Y; Zhao S; Xu H; Ren L; An T; Wang Q; Yu S
    Oncotarget; 2015 Oct; 6(30):29129-42. PubMed ID: 26320176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown ATG4C inhibits gliomas progression and promotes temozolomide chemosensitivity by suppressing autophagic flux.
    Wen ZP; Zeng WJ; Chen YH; Li H; Wang JY; Cheng Q; Yu J; Zhou HH; Liu ZZ; Xiao J; Chen XP
    J Exp Clin Cancer Res; 2019 Jul; 38(1):298. PubMed ID: 31291988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TUBA1C is a potential new prognostic biomarker and promotes bladder urothelial carcinoma progression by regulating the cell cycle.
    Jiang Y; Zhu C; Huang H; Huang G; Fu B; Xi X
    BMC Cancer; 2023 Aug; 23(1):716. PubMed ID: 37528357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleolar and spindle-associated protein 1 is a tumor grade correlated prognosis marker for glioma patients.
    Zhu T; Xie P; Gao YF; Huang MS; Li X; Zhang W; Zhou HH; Liu ZQ
    CNS Neurosci Ther; 2018 Mar; 24(3):178-186. PubMed ID: 29336114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of ADAMDEC1 inhibits the progression of glioma in vitro.
    Liu X; Huang H; Li X; Zheng X; Zhou C; Xue B; He J; Zhang Y; Liu L
    Histol Histopathol; 2020 Sep; 35(9):997-1005. PubMed ID: 32378728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic role of SOX9 expression in human malignant glioma.
    Wang L; He S; Yuan J; Mao X; Cao Y; Zong J; Tu Y; Zhang Y
    Med Oncol; 2012 Dec; 29(5):3484-90. PubMed ID: 22714060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated expression of TUBA1C in breast cancer predicts poor prognosis.
    Zhao Y; Wang W; Li J; Du J; Xie Q; Wang M; Liu Z; Huo X; Zhao F; Ren D; Zhao J; Shen G
    PLoS One; 2023; 18(11):e0263710. PubMed ID: 38032902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAICS is related to glioma grade and can promote glioma growth and migration.
    Du B; Zhang Z; Di W; Xu W; Yang L; Zhang S; He G; Yang R; Wang M
    J Cell Mol Med; 2021 Aug; 25(16):7720-7733. PubMed ID: 34173716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.